We examined the hypothesis that senescence represents a proximate mechanism by which the kidney is damaged in type 2 diabetic nephropathy (DN). As a first step, we studied whether the senescence-associated ␤-galactosidase (SA-␤-Gal) and the cell cycle inhibitor p16
which could hinder the limited ability of aged kidney to repair and maintain epithelial functions (24, 25) . Cell senescence is characterized by an irreversible growth arrest and functional and morphological changes (2) , including enhanced expression of senescence markers, such as senescence-associated ␤-galactosidase (SA-␤-Gal), and different sets of genes, including negative regulators of the cell cycle (2, 17, 18) . In vitro studies support the hypothesis that diabetes may accelerate cell and organ senescence in humans. Hyperglycemia induces premature replicative senescence in human skin fibroblasts, an effect that is tightly coupled to larger cell volume in skin fibroblasts from patients with diabetic nephropathy (3, 21) . In addition, a role of hyperglycemia in kidney cell senescence has been observed in cultured mesangial cells (1, 34, 35, 37) . However, how these observations from in vitro studies apply to human diabetic nephropathy is still unexplored.
In this study, we tested the hypothesis that the acceleration of senescence represents a relevant mechanism by which kidney cells are injured in diabetic nephropathy. With this in mind, we used different markers for the study of senescence in kidney biopsies of patients with type 2 diabetic nephropathy at different clinical stages. As a next step, we examined the in vitro effects of hyperglycemia on senescence markers, replicative ability, and telomere length in PTECs stimulated to divide in vitro. Our results show that the kidneys with type 2 diabetic nephropathy and proteinuria display an accelerated senescent phenotype, thus suggesting a role for somatic cell senescence as a mechanism of diabetic nephropathy. In addition, a similar senescent pattern displayed by tubule cells in renal biopsies was observed when incubating proximal tubule cells under high glucose media. These changes were associated with shortening tubular telomere length in vitro. Our findings show that senescence is accelerated in the kidney of patients with type 2 diabetic nephropathy, thus reinforcing the role of the metabolic syndrome on biological aging of tissues.
MATERIALS AND METHODS
Reagents. Media and additives for culture of PTEC cells, 5-bromo-2-␤-deoxy-uridine (BrdU) as well as 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside, acryl amide, and other reagents for SDS-PAGE were purchased from Sigma Chemical (St. Louis, MO). Coomassie protein assay reagent was obtained from Pierce (Rockford, IL). Tissue culture plates and dishes were from Corning. Anti-human p21 monoclonal, anti-human p53 polyclonal, and anti-human p16 INK4A monoclonal (Clone F12) antibody (Ab) were obtained by Santa Cruz Biotechnology (Santa Cruz, CA), and anti-human retinoblastoma (Rb) protein monoclonal Ab was obtained by Pharmingen BD (Franklin Lakes, NJ). The biotin-streptavidin-amplified detection system was obtained from Vector Laboratories (Burlingame, CA), and Eukitt was from Kindler (Freiburg, Germany). Horseradish peroxidase-conjugated secondary Ab, nitrocellulose, and positively charged nylon membrane were from GE Healthcare (Buckinghamshire, England). Immobilon Western chemiluminescent horseradish peroxidase substrate was obtained from Millipore (Billerica, MA). The telomere length assay kit was purchased from Roche (Mannheim, Germany).
Patients. Seventeen patients with type 2 diabetic nephropathy entered into this study from the Department of Internal Medicine, Nephrology Division, Genoa University ( Table 1 ). The study was part of a larger study in patients with type 2 diabetic nephropathy, and it was approved by the Ethical Committee of the Department of Internal Medicine, Genoa University. The procedures were in accordance with the Declaration of Helsinki. The age of patients ranged from 50 to 70 yr (mean 61 yr). Diabetic subjects were further classified into two groups based on urine protein excretion and renal function. The first group of subjects had early clinical diabetic nephropathy (defined by proteinuria 500 -2,000 mg/day and serum creatinine Յ1.4 mg/dl). The second group of subjects had an advanced clinical nephropathy (proteinuria Ͼ2,000 mg/day and/or serum creatinine Ͼ1.4 mg/dl). Systolic blood pressure levels were higher, and the duration of diabetes longer in patients with more advanced disease. There were no significant differences in age, body weight, HbA1c, blood glucose, and serum cholesterol between the two groups. Serum triglycerides tended to be greater in subjects with advanced diabetic nephropathy. In every case, the diagnosis of diabetic nephropathy was based on light microscopy and immunofluorescence. Normal portions of kidney tissue from nephrectomies for renal carcinoma (n ϭ 9, 7 male/2 female, mean age 60 yr, range 58 -67 yr) were examined as a control group.
All kidney biopsy specimens were analyzed by the same pathologist (Dr. F. Ferrario). The morphological changes in kidney biopsies were considered as previously described (23, 32) for the following categories: glomerular sclerosis (nodular or diffuse), glomerular ischemic lesions, mesangial proliferation, interstitial fibrosis, interstitial inflammation, tubular atrophy, atherosclerosis, and arterial hyalinosis. Individual scores ranged from 0 to 3. For interstitial fibrosis, score 0 ϭ no interstitial fibrosis; score 1 ϭ interstitial fibrosis in up to 25%; score 2 ϭ interstitial fibrosis in 26 -50%; and score 3 ϭ interstitial was performed as described previously (31) . p16 INK4A /SA-␤-Gal coexpression was evaluated in frozen tissue. At least five (range 5-10) glomeruli from each biopsy were systematically serially sectioned. These sections were used to estimate cell number by light microscopy. Endothelial cells were identified as being within the capillary lumen and integral to the filtration surface or mesangiocapillary surface, mesangial cells were defined as those completely within the mesangium, and podocytes were defined as being in the urinary space within the glomerular tuft. Proximal and distal tubular cells were identified primarily by morphological criteria. The percentage of p16 INK4A -positive nuclei (nuclear p16 INK4A ) was assessed for glomeruli and tubules and expressed as percent positive cells. On the average, ϳ800 glomerular and ϳ1,200 tubular nuclei were counted in controls and in diabetic subjects, respectively. The nuclear ϩ cytoplasmic expression of p16
INK4A in tubules was examined by image analysis and expressed as percent positive areas (30) . SA-␤-Gal tubular cytoplasmic staining was assessed by counting the percentage of tubular cross sections that showed positive cytoplasmic staining. All specimens for senescence markers detection were analyzed by the same pathologist (Dr. D. Verzola).
Cell culture. The effect of hyperglycemia on senescence and telomere length was studied in primary cultures of proximal tubular cells obtained from normal portions of kidney tissue obtained from nephrectomies for renal carcinoma (n ϭ 7, 6 male/1 female, mean age 62 yr, range 60 -67 yr). Subjects were nonsmokers, nondiabetics, and free of cardiovascular disease or hypertension, variables that could influence telomere length (5) . Human PTECs were isolated as previously described (31) . Briefly, renal cortical tissue was obtained from kidneys that were removed for circumscribed tumors. Cortical specimens were cut into small cubes and passed through a series of mesh sieves of diminishing pore size. PTECs were collected on the 53-m sieve and digested with collagenase (750 U/ml) at 37°C for 15 min. Tubular cells were isolated by centrifugation and grown in modified Eagle's medium supplemented as previously described (33) .
Cell treatments. PTECs were passaged three times for 28 days in normal growth medium. During this period, the cultures were regularly fed twice weekly. PTECs were then passaged under different conditions as follows: 1) baseline medium containing 5. Cell proliferation. Incorporation of BrdU was measured as an index of DNA synthesis. PTECs were grown for 5, 10, or 15 days in NG, HG, or M medium. BrdU (10 mol/l) was directly added to the culture medium for 1 h. The cells were detached and incubated on poly-L-lysine coated glass slides for 40 min at 4°C. Then, the spots were fixed in 70% ethanol. The slides were immersed in 0.07 N NaOH for 2 min, and the base was neutralized in PBS, pH 8.5. 20 l of antibody to BrdU was mixed with 50 l of 0.5% Tween 20/PBS and incubated for 30 min. Cells were exposed to biotinylated conjugated secondary antibody (1:100 in PBS) for 30 min and, then, to FITCstreptavidin (1:400 in PBS) for 30 min. Nuclei were counterstained with propidium iodide. Slides were observed and counted under a fluorescence microscope, and positive cells were expressed as a percentage of total cells counted. For the calculation of population doubling time (11) , the cell number was measured manually with a hemocytometer.
Western blot analysis. The cells were scraped and suspended in cold lysis buffer [20 mmol/l HEPES; 150 mmol/l NaCl; 10% (vol/vol) glycerol; 0.5% (vol/vol) NP-40; 1 mmol/l EDTA; 2.5 mmol/l DTT; 10 g/l aprotinin, leupeptin, and pepstatin A; and 1 mmol/l PMSF and Na 3VO4]. Protein concentration was determined by using the Coomassie protein reagent, and the same amounts were resolved on 7-15% SDS-polyacrylamide gels and electrotransferred to a nitrocellulose membrane. Blots were blocked for 1 h at room temperature in PBS 5% milk. The membrane was incubated overnight at 4°C with anti-human p16
INK4A , anti-human Rb protein, anti-human p53, and anti-human p21 antibodies. The membranes were incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Immunoblots were developed with ECL detection system.
Telomere length. Mean telomere terminal restriction fragment (TRF) length analysis was performed with the TAGGG telomere length assay kit. Ten micrograms of genomic DNA was digested overnight with a high concentration (50 U/ml) of HinfI and RsaI and separated on 0.8% agarose gel. After electrophoresis, DNA was denatured with 0.5M NaOH/1.5 M NaCl, neutralized with 0.5 M Tris ⅐ HCl/3 M NaCl and transferred onto a positively charged nylon membrane. The membrane was hybridized to a digoxigenin-labeled telomere specific probe for 3 h at 65°C and then washed twice in 2ϫ SSC/0.1% SDS for 15 min at room temperature and twice in 0.5ϫ SSC/0.025% SDS for 20 min at 39°C. The membrane was finally incubated with a digoxigenin-specific antibody, covalently coupled to alkaline phosphatase. The telomeric probe was visualized by a highly sensitive chemiluminescent substrate for alkaline phosphatase CDPstar (phenylphosphate substituted 1,2 dioxetane). To measure the mean TRF length of DNA samples, the membrane was exposed to Hyper film ECL (Amersham). The mean telomere length, defined as the strongest density peak, of the samples examined was determined compared with DNA of standard lengths, using KODAK 1D image analysis software (Carestream Health, Rochester, NY; Ref. 12). The coefficient of variation range for the mean TRF length by this method is 4%.
Statistical analysis Data are presented as means Ϯ SE or, when skewed, median (range). The Statview statistical package (Cary, NC) was used for the analysis. Means were compared for statistically significant differences by t-test, Mann-Whitney, or ANOVA when two or more than two groups, respectively, were involved. Relationships between parameters were analyzed using simple regression analysis or Spearman test, as required. Multiple regression analysis was performed to assess which clinical metabolic parameters [body mass index (BMI), LDL cholesterol, HbA1c, and blood glucose] or structural changes (glomerular ischemic changes, tubular atrophy, and interstitial fibrosis), which were significantly related in simple regression analysis, were independent predictors of senescence. A twotailed P value Ͻ0.05 was considered statistically significant.
RESULTS

p16
INK4A protein expression in type 2 diabetic nephropathy. Normal kidneys showed p16
INK4A staining in 1.3 Ϯ 0.63% of glomerular cells (Fig. 1A, arrowheads ), 1.5 Ϯ 0.27% of tubular cells (Fig. 1B) , and 0.3 Ϯ 0.6% of vessels ( Table 2) . Only scanty interstitial cells were p16
INK4A positive (0.1 Ϯ 0.2%). In addition to the nuclear staining, 70% of normal kidneys showed tubular cytoplasmic p16
INK4A expression (mean score: 0.1 Ϯ 0.04). These findings are in accordance with what has been previously reported (28, 18, 19) .
The percentage of p16 INK4A positive glomeruli (19.8 Ϯ 0.5 vs. 13.7 Ϯ 0.5% in patients and controls, respectively; P Ͼ 0.05), as well as the percentage of glomerular p16
INK4A positive nuclei (1.5 Ϯ 0.37 vs. 1.3 Ϯ 0.63% in patients and controls, respectively; P Ͼ 0.05), was similar in patients with diabetic nephropathy and controls (Table 2 ). When nuclear p16 INK4A expression in glomeruli was analyzed by cell type ( Fig. 1; Table 2 ), podocyte nuclear p16
INK4A staining was increased in diabetic nephropathy compared with normal kidneys (P ϭ 0.04). In contrast, the p16 INK4A signal in mesangialendothelial cell nuclei and in the arterial vessels was similar to controls.
Diabetic patients showed a strikingly increased p16 INK4A expression in tubular nuclei (ϳ3-fold increase; Fig. 1 , E and F; Table 2 ) and tubular nuclei and cytoplasm (mean score: 0.30 Ϯ 0.08 vs 0.1 Ϯ 0.04 in controls; P Ͻ 0.05 ).
SA-␤-Gal expression is enhanced in the kidney of patients with type 2 diabetic nephropathy.
SA-␤-Gal staining was approximately threefold higher (32.6 Ϯ 17 vs. 7.35 Ϯ 5.8% positive tubuli in patients vs. controls; P Ͻ 0.05) in the tubular compartment of diabetic kidneys with early disease than in controls (Fig. 2) and did not increase further in advanced diabetic nephropathy. The SA-␤-Gal signal was predominantly confined to tubular cells, and it was also only weakly detected in glomerular parietal cells, podocytes, and vascular endothelial cells (Fig. 2) . Tubular SA-␤-Gal staining was directly related to the nuclear ϩ cytoplasmic expression of p16 INK4A (rϭ 0.63; P Ͻ 0.03), but not nuclear p16 INK4A , in the tubular compartment.
When we examined the SA-␤-Gal and p16 coexpression in single sections, some tubule cells showed a complete coexpression of these two markers, while others showed an isolated expression of SA-␤-Gal or p16 (Fig. 3) . This suggests that aging phenotypes may be differently expressed at the same time in the same tissue or that, alternatively, also p16-independent mechanisms may account for tubular senescent changes. In addition, it is also possible that hyperglycemia-stimulated p16 INK4A expression is transient but causes permanent changes.
Determinants of p16
INK4A and SA-␤-Gal expressions. By univariate linear regression analysis, nuclear p16
INK4A expression was strongly associated with proteinuria in glomeruli (r ϭ 0.72; P Ͻ 0.002) but not in tubuli (r ϭ 0.13; P Ͼ 0.05; Table 3 ; Fig. 4 ). In addition, glomerular p16
INK4A was not related to estimated glomerular filtration rate (GFR) at the time of biopsy, blood pressure, BMI, or other metabolic parameters. The enhanced tubular cell nuclear ϩ cytoplasmic p16
INK4A expression was directly associated with BMI (r ϭ 0.82; P Ͻ 0.001; Table 3 ; Fig. 5 ), plasma LDL cholesterol (r ϭ 0.49; P Ͻ 0.05), and HbA1c (r ϭ 0.49; P Ͻ 0.05; Fig. 5 ). Similarly SA-␤-Gal staining in tubules was directly associated with BMI and blood glucose at the time of the biopsy (Fig. 6 ). All these parameters played an independent role in senescent changes in the kidney, as assessed by multiple regression analysis (Table 4 ) . 
Histological associations. Both p16
INK4A and SA-␤-Gal expressions were already upregulated in patients with proteinuria and did not further change in advanced diabetic disease. A few significant relations were observed between individual structural kidney changes and senescence markers (Table 5) . SA-␤-Gal staining in tubules was directly associated with interstitial fibrosis (r ϭ 0.49; P Ͻ 0.05), while tubular p16
INK4A expression (%positive nuclei) was directly associated with tubule atrophy (r ϭ 0.64; P Ͻ 0.02) and glomerular ischemic lesions (r ϭ 0.76; P Ͻ 0.01). Multiple regression analysis was used to discover which proportion of variations in tubular p16
INK4A or SA-␤-Gal staining in tubules (as dependent variables) was accounted for by glomerular ischemic lesions, interstitial fibrosis, and tubular atrophy (independent variables), which were significantly related in simple regression analysis. The aforementioned structural changes did not play an independent role in variations in tubule senescence markers (model r 2 ϭ 0.050; P ϭ NS; individual data not shown).
Cultured proximal tubular cells show accelerated senescence when exposed to high glucose media. After the observation of enhanced expression of senescence markers in the tubular compartment of renal biopsies and of their association with BMI, blood glucose, or HbA1c, we tested the hypothesis that high ambient glucose boosts the pathways involved in cellular senescence in tubule cells. PTECs were cultured for 5, 10, and 15 days in NG (5.5 mM, HG; 30 mM), or M (24.5 mM; osmotic control) containing media. Figure 7 shows that both NG and HG decreased the nuclear incorporation of BrdU (an expression of proliferative capacity) with time. However, DNA syntheses were significantly decreased by HG after 15 days. The PTEC population doubling time was 34 Ϯ 11 and 70 Ϯ 7 h at 5 days under NG and HG, respectively (P ϭ NS). The population doubling time increased by threefold as an effect of replicative senescence in cells cultivated under NG for 15 days (P Ͻ 0.05). However, PTECs proliferated at even lower rates under HG (population doubling time 10 days: NG ϭ 74 Ϯ 13, HG ϭ 115 Ϯ 13 h, P ϭ NS; 15 days NG ϭ 125 Ϯ 13, HG ϭ 206 Ϯ 15 h, P Ͻ 0.05). These data indicate that the passaged PTECs had limited life span in vitro, which is further decreased by high glucose media.
Next, we used the measurement of SA-␤-Gal activity to determine whether the replicative arrest was associated with senescence. Replicative senescence was associated with a marked increase in the cytochemically detectable SA-␤-Gal activity (Fig. 8, A and B) . In addition, after 15 days SA-␤-Gal activity was significantly increased by HG, compared with NG (HG 23.1 Ϯ 4 and NG 12.3 Ϯ 3.6; P ϭ 0.007; Fig. 8C) .
HG upregulates p16 INK4A and Rb proteins in PTECs. To investigate the role of the cell cycle check point regulators in controlling HG-induced senescence, we evaluated the activation of the two pathways potentially implicated in senescence induction: the p53/p21 pathway and the retinoblastoma (a downstream target of p16
INK4A
) pathway. Therefore, we studied the p53, p21, p16
, and Rb expressions (Western blot) in PTECs cultured in NG or HG media up to 15 days. Extracts prepared from early passage human PTECs contained barely detectable levels of p16 INK4A and Rb proteins (Fig. 8D) . In sharp contrast, both p16 INK4A and Rb proteins were highly expressed in PTECs grown under HG medium (Fig. 8, D-E) . Of note, p53 and p21 were not expressed, neither at the baseline nor after HG (data not shown). According to these observations, HG media activate both the p16 telomere-dependent pathway and the p16/pRB-senescent pathway in renal epithelial cells in vitro. INK4A has been shown to induce cellular senescence also independently of telomere attrition (2) . We thus investigated the effect of hyperglycemia on telomere length in PTECs, as described in the MATERIALS AND METHODS. Before expansion, TRF lengths were ϳ13 kb, a value similar to those previously observed in the human kidney (18, 19) . Four lines, which were maximally expanded in culture with NG or HG media, were harvested at growth arrest for genomic DNA analysis. Figure 9 shows the change in telomere length of cell cultures as a function of glucose concentration. Senescent, HG grown PTECs had lower TRF length than those grown in NG. Mean TRF lengths decreased from 11.25 to 8.92 kb as an effect of replicative senescence; in addition mean TRF decreased further to 4.39 kb in expanded cells cultivated under HG (Fig.   9 ). These results revealed significant loss of telomere DNA in the experimental conditions simulating diabetes mellities.
DISCUSSION
In this study, we tested the hypothesis that diabetic nephropathy is associated with an acceleration of senescent phenotype in kidney cells. With this in mind, we used different assays for the study of senescence markers in kidney biopsies of patients with type 2 diabetic nephropathy at different clinical stages and examined the association of several clinical parameters as potential predictors of kidney cell senescence. Previous studies (18) have shown that the nuclear p16
INK4A expression increases progressively with age in several kidney cell types and that this increase is more pronounced in tubular cells. In our study, an acceleration of senescent phenotype was observed mainly in tubule cells and, to a lesser extent, podocytes. As a (Fig. 7, D-E) . In sharp contrast, both p16 INK4A and Rb proteins were highly expressed in PTECs grown under high glucose medium (Fig. 7, D-E) . Contrarywise, p53 and p21 were not expressed, neither at the baseline nor after HG (data not shown). Tubulin was loading control for both pRB and p16. Results are means Ϯ SE obtained from triplicate experiments. complement to the observed upregulation of senescence-associated SA-␤-Gal staining and the cell cycle inhibitor p16 INK4A , a prominent senescent phenotype was shown by human proximal tubular cells stimulated to divide in vitro under high glucose media, suggesting that the hyperglycemic milieu per se induces tubular senescence. Finally, the hyperglycemia-associated senescent phenotype was associated with a consistent decrease in tubule cell telomeric length and replication. Taken together, these findings strongly suggest that diabetic nephropathy is associated with premature kidney aging and that hyperglycemia is, at least in part, responsible for the observed changes.
The glomerular expression of p16 INK4A , a major cell cycle regulatory protein associated with replicative senescence, increases with age (18) and in stress conditions, such as chronic kidney transplant rejection (20) . In our study, kidneys with diabetic nephropathy displayed an increased expression of senescence markers p16
INK4A and SA-␤-Gal compared with age-matched controls, indicating that an age effect could not be responsible for our findings. In addition, the estimated GFR at the time of biopsy did not correlate with p16
INK4A or SA-␤-Gal staining (P Ͼ 0.05), suggesting that renal failure per se is not responsible for the activation of senescence. Glomerular injury frequently results in proteinuria, and filtered proteins are potential mediators of tubular epithelial cell injury, contributing to chronic tubulointerstitial changes (6) . In patients with glomerulonephritis, p16
INK4A expression in glomerular and tubular cells has been observed to be higher in kidneys with proteinuria (28) . In patients with diabetic nephropathy studied here, the p16
INK4A response appeared to vary in different cell types. A small number (1-3%) of glomerular cells were p16 INK4A positive. In addition, glomerular p16 INK4A was similarly expressed in proteinuric patients and controls. However, it was expressed mainly in podocytes, which are considered to be terminally differentiated cells. It is of note that podocyte loss in diabetic nephropathy is believed to result in permanent alterations in the glomerular filtration barrier (6, 8, 22) . In our study, we found an association between glomerular p16 INK4A and proteinuria, suggesting that a senescent phenotype in glomerular cells is associated with altered permeability.
SA-␤-Gal is a well-known marker of cellular senescence (9) . The presence of SA-␤-Gal is independent of DNA synthesis and reflects the change in cell function that accompanies senescence (9) . In accordance with the p16 INK4A data, SA-␤-Gal expression was markedly upregulated in tubular cells, whereas the signal was weak and mainly confined to podocytes in the glomeruli. Similar findings have been observed in animal models of kidney senescence (15) . Of note, accelerated senescence was already observed in proteinuric patients with normal or subnormal GFR and only modest chronic changes at the time of their biopsy, suggesting that cell senescence is an early finding in human clinical diabetic nephropathy.
In vitro studies show that tubular cells undergoing senescence express TGF-␤1 with advancing age (10) . In keeping with these findings, in the aging kidney, p16
INK4A gene expression independently correlates with aging and age-associated histological changes (19) . In our study, at univariate analysis, tubular p16
INK4A expression was directly related to the degree of glomerular ischemic lesions, suggesting that glomerular ischemia favors the downstream occurrence of senescence in the tubular compartment. In addition, tubular p16
INK4A expression was directly associated with tubule atrophy, while tubular SA-␤-Gal staining was directly associated with interstitial fibrosis. These findings raise the possibility that p16
INK4A and SA-␤-Gal play different roles (or, alternatively, are an expression of different mechanisms) in chronic tubulointerstitial changes in type 2 diabetic kidney disease. However, in multiple regression neither glomerular ischemic lesions nor interstitial fibrosis/tubular atrophy played an independent role on variations in tubule senescence markers. Of note, these lesions often progress sinchronously in patients with type 2 diabetic nephropathy (23) .
In our study, although both p16 INK4A and SA-␤-Gal were both overexpressed in the diabetic kidney, their association was not very strong, with only 40% of changes in SA-␤-Gal being accounted for the increase in p16
INK4A in linear regres- 
